The origin-of-cell harboring cancer-driving mutations in human glioblastoma

Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term...

Full description

Saved in:
Bibliographic Details
Published inBMB reports Vol. 51; no. 10; pp. 481 - 483
Main Authors Lee, Joo Ho, Lee, Jeong Ho
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society for Biochemistry and Molecular Biology 01.10.2018
생화학분자생물학회
Subjects
Online AccessGet full text
ISSN1976-6696
1976-670X
DOI10.5483/BMBRep.2018.51.10.233

Cover

Abstract Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. [BMB Reports 2018; 51(10): 481-483].
AbstractList Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM.
Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. KCI Citation Count: 0
Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver mutations is the fundamental issue for understanding the nature of GBM and developing the effective therapeutic target. It has been a long-term hypothesis that neural stem cells in the subventricular zone (SVZ) might be the origin-of-cells in human glioblastoma since they are known to have life-long proliferative activity and acquire somatic mutations. However, the cell of origin for GBM remains controversial due to lack of direct evidence thereof in human GBM. Our recent study using various sequencing techniques in triple matched samples such as tumor-free SVZ, tumor, and normal tissues from human patients identified the clonal relationship of driver mutations between GBM and tumor-free SVZ harboring neural stem cells (NSCs). Tumor-free SVZ tissue away from the tumor contained low-level GBM driver mutations (as low as 1% allelic frequency) that were found in the dominant clones in its matching tumors. Moreover, via single-cell sequencing and microdissection, it was discovered that astrocyte-like NSCs accumulating driver mutations evolved into GBM with clonal expansion. Furthermore, mutagenesis of cancer-driving genes of NSCs in mice leads to migration of mutant cells from SVZ to distant brain and development of high-grade glioma through the aberrant growth of oligodendrocyte precursor lineage. Altogether, the present study provides the first direct evidence that NSCs in human SVZ is the cell of origin that develops the driver mutations of GBM. [BMB Reports 2018; 51(10): 481-483].
Author Lee, Jeong Ho
Lee, Joo Ho
AuthorAffiliation 1 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea
2 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea
AuthorAffiliation_xml – name: 2 Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea
– name: 1 Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea
Author_xml – sequence: 1
  givenname: Joo Ho
  surname: Lee
  fullname: Lee, Joo Ho
  organization: Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea
– sequence: 2
  givenname: Jeong Ho
  surname: Lee
  fullname: Lee, Jeong Ho
  organization: Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30269745$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002398103$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNpVkN1LwzAUxYNM3Jz7E5S--tCaNM1HX4Rt-DGcCGOCbyVN0jasTUbaDfzvrZsTfTr3nnvO7-FegoF1VgNwjWBEEo7vZq-zld5GMUQ8Iijq7RjjMzBCKaMhZfBjcJppSodg0rYmhwRjRhlPL8AQw5imLCEj8LKudOC8KY0NXRFKXddBJXzeW7YMpLBS-1B5s_9em10nOuNsGxgbVLtG2KCsjctr0XauEVfgvBB1qyc_Ogbvjw_r-XO4fHtazKfLUCYJ6UIiCpZQrpHkKo-LXjTSlDKVF4pyoajgaW9ApRItGcSKi5xAyBTLJUVU4zG4PXKtL7KNNJkT5qClyzY-m67Wi4xRRCDCffb-mN3u8kYrqW3nRZ1tvWmE_zw0_1-sqXrOPqMxJpCnPeDmL-C3eXoh_gIX5Xn5
CitedBy_id crossref_primary_10_1007_s11060_025_04965_7
crossref_primary_10_4252_wjsc_v13_i7_877
crossref_primary_10_1016_j_tins_2024_07_004
crossref_primary_10_1109_TMI_2020_3024264
crossref_primary_10_12786_bn_2022_15_e24
crossref_primary_10_5306_wjco_v15_i2_178
crossref_primary_10_1088_1361_6420_ab649c
crossref_primary_10_1186_s12943_025_02273_2
crossref_primary_10_1002_mc_23720
ContentType Journal Article
Copyright Copyright © 2018 by the The Korean Society for Biochemistry and Molecular Biology 2018
Copyright_xml – notice: Copyright © 2018 by the The Korean Society for Biochemistry and Molecular Biology 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
5PM
ACYCR
DOI 10.5483/BMBRep.2018.51.10.233
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1976-670X
EndPage 483
ExternalDocumentID oai_kci_go_kr_ARTI_7615013
PMC6235089
30269745
Genre News
GroupedDBID .UV
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
NPM
---
23N
2WC
5GY
5PM
5VS
87B
9ZL
AAFWJ
ACGFO
ACYCR
ADBBV
AENEX
AFPKN
AOIJS
BAWUL
BCNDV
DIK
E3Z
F5P
GROUPED_DOAJ
GX1
HH5
HYE
HZB
JDI
KQ8
OVT
RNS
RPM
TR2
53G
85H
IPNFZ
M~E
OK1
RIG
ID FETCH-LOGICAL-c445t-5af7468e1c8db2f1c8e1e667dbfd68ad6a891e60dd4ec703d8ab5007d7bc616e3
ISSN 1976-6696
IngestDate Tue Nov 21 21:47:25 EST 2023
Thu Aug 21 14:01:05 EDT 2025
Fri Feb 23 03:39:21 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c445t-5af7468e1c8db2f1c8e1e667dbfd68ad6a891e60dd4ec703d8ab5007d7bc616e3
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC6235089
PMID 30269745
PageCount 3
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_7615013
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6235089
pubmed_primary_30269745
PublicationCentury 2000
PublicationDate 2018-10-01
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle BMB reports
PublicationTitleAlternate BMB Rep
PublicationYear 2018
Publisher Korean Society for Biochemistry and Molecular Biology
생화학분자생물학회
Publisher_xml – name: Korean Society for Biochemistry and Molecular Biology
– name: 생화학분자생물학회
SSID ssib053376789
ssj0061272
Score 2.2420666
Snippet Glioblastoma (GBM) is the most common and aggressive form of human adult brain malignancy. The identification of the cell of origin harboring cancer-driver...
SourceID nrf
pubmedcentral
pubmed
SourceType Open Website
Open Access Repository
Index Database
StartPage 481
SubjectTerms Astrocytes - pathology
Glioblastoma - genetics
Glioblastoma - pathology
Humans
Lateral Ventricles - pathology
Mutation - genetics
Neural Stem Cells - metabolism
Neural Stem Cells - pathology
화학
Title The origin-of-cell harboring cancer-driving mutations in human glioblastoma
URI https://www.ncbi.nlm.nih.gov/pubmed/30269745
https://pubmed.ncbi.nlm.nih.gov/PMC6235089
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002398103
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX BMB Reports, 2018, 51(10), , pp.481-483
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb5swFLbSTtp6mbrf2dYKTbtVziBgG45r1Crb1KqHVsoN-WeL2kKFiDTtr98zNgSiHrZeAL0QQvwe9vfM5_ch9NUwoyMtDObacAz5Rox5qOCIcCMM4GsjW4LsOV1eJT9XZDWZ_B6wltaNmMk_j64reYpXwQZ-tatk_8Oz_UXBAMfgX9iCh2H7zz52yla4MtjOwR_d8Fo4Tp20_qyxqot2zuB-3Wx4406Z7_quqASg56bynXP_cve4e5ewzdepqqNltW3UVq_Im_0EQpT2VDRPx69qO-c_JIkeF1aty8nNOb5HJ9XrFTIHvVQEeAZTmvl61gMbC1fDbtbXlfXhFA46zcSJtvjxN3HCNttdO2RWtsQEtABkJpaSl85INGuZ7KPzwUMP962_Y0gvIVsim5Gu5x9enC0A9gE2zXbQszkD1DWe5wEMzGhbh9-N6QADWxmw_s-6tWD2nr49ekd76Hn38wBaytoMAM6YfDtAM5f76KVPQ4LvLqZeoYkuX6MXi84db9AviK1gHFtBH1vBOLaCPraCogza2AqGsfUWXZ2eXC6W2AtvYJkkpMHwnLKEpjqSqRJzAzt4nillShhFU64oTzMwhEolWsKQoVIuCIBNxYSkEdXxO7RbVqX-gIKEZCRWjGZcRAlhUoQ6VgKyEJnOORF8ir5A6-S3sshtoXO7v67y2zqHdO5HzqxcQRRP0XvXZvmDK8GSd407RWzUmv0J9mLjT8ripq2e7h3_8cnf_IT2No_RZ7Tb1Gt9AMi0EYdo5_zi7LANpb8bfpHl
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+origin-of-cell+harboring+cancer-driving+mutations+in+human+glioblastoma&rft.jtitle=BMB+reports&rft.au=Lee%2C+Joo+Ho&rft.au=Lee%2C+Jeong+Ho&rft.date=2018-10-01&rft.pub=Korean+Society+for+Biochemistry+and+Molecular+Biology&rft.issn=1976-6696&rft.eissn=1976-670X&rft.volume=51&rft.issue=10&rft.spage=481&rft.epage=483&rft_id=info:doi/10.5483%2FBMBRep.2018.51.10.233&rft_id=info%3Apmid%2F30269745&rft.externalDocID=PMC6235089
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-6696&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-6696&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-6696&client=summon